Investors in search of momentum might have Teucrium Soybean Fund SOYB on radar now. The fund just l
Investors in search of momentum might have Teucrium Soybean Fund SOYB on radar now. The fund just lately hit a brand new 52-week excessive. Shares of SOYB are up roughly 24.6% from their 52-week low of $13.27/share.
However might there be extra positive factors forward for this ETF? Let’s check out the fund and the near-term outlook to get a greater concept of the place it is perhaps headed.
SOYB in Focus
This underlying index appears to be like to replicate the every day adjustments of a weighted common of the closing costs for 3 futures contracts for soybeans which can be traded on the CBOT. The three contracts might be: 2nd-to-expire contract, Third-to-expire contract and the contract expiring within the November following the expiration month of the Third-to-expire contract. The expense ratio is 3.15% (see all Agricultural ETFs right here).
Why the transfer?
Soybean futures gained currently, on information of some Chinese language purchases. This has most likely acted as a tailwind for the product.
Extra Good points Forward?
The fund has a optimistic weighted alpha of 11.40. So, there’s a first rate outlook forward for individuals who need to trip this surging ETF a shade additional.
Need key ETF data delivered straight to your inbox?
Zacks’ free Fund E-newsletter will temporary you on high information and evaluation, in addition to top-performing ETFs, every week. Get it free >>
Need the most recent suggestions from Zacks Funding Analysis? Right now, you’ll be able to obtain 7 Greatest Shares for the Subsequent 30 Days. Click on to get this free report
Teucrium Soybean ETF (SOYB): ETF Analysis Experiences
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
Need the most recent suggestions from Zacks Funding Analysis? Right now, you’ll be able to obtain 7 Greatest Shares for the Subsequent 30 Days. Click on to get this free report
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.